# Mark Roschewski, M.D., Bethesda, MD – FDA Inspections

Source: https://www.keypedia.com/companies/mark-roschewski-md/ea0723cb-f67f-4b83-a845-0e1c0b6e9f92

> Inspection records and compliance data for Mark Roschewski, M.D. in Bethesda, Maryland. 2 FDA inspections on record (1 OAI), last inspected April 15, 2024.

---

## Details

- Name: Mark Roschewski, M.D.
- FEI Number: 3018118045
- Address Line 1: Building 10, 10 Center Drive
- City: Bethesda
- State: Maryland
- Zip Code: 20892
- Country Name: United States
- Address: Building 10, 10 Center Drive, Bethesda, Maryland 20892, United States
- Country: United States

## Related Documents

- [483 - Mark Roschewski, M.D. - 2024-04-15](https://www.keypedia.com/records/483/mark-roschewski-md/3a4a08e1-c5d7-4f04-9679-003c7d47f83a) — source: FDA, date: April 15, 2024
- [FDA Inspection 1235997 - Mark Roschewski, M.D. - 2024-04-15](https://www.keypedia.com/records/fda_inspections/mark-roschewski-md/0aa772c0-4b0b-43a0-9375-6c2220b68c90) — classification: No Action Indicated (NAI), source: FDA, date: April 15, 2024
- [483 - Mark Roschewski, M.D. - 2021-05-11](https://www.keypedia.com/records/483/mark-roschewski-md/43f19a7d-e9e3-40a3-bc78-e6f33e58e89c) — source: FDA, date: May 11, 2021
- [FDA Inspection 1141689 - Mark Roschewski, M.D. - 2021-05-11](https://www.keypedia.com/records/fda_inspections/mark-roschewski-md/fb9d888a-6b1f-4233-b997-04a383e7defc) — classification: Official Action Indicated (OAI), source: FDA, date: May 11, 2021

## Related Companies

- [PAREXEL Early Phase Clinical Unit](https://www.keypedia.com/companies/parexel-early-phase-clinical-unit/9748c7f3-64a9-490d-994d-e02b56d9d1d0)
- [John J. Wroblewski, M.D.](https://www.keypedia.com/companies/john-j-wroblewski-md/152a4c6a-a7f1-43ad-a4ab-ab9c6b949452)
- [Reveragen Biopharma Inc.](https://www.keypedia.com/companies/reveragen-biopharma-inc/eaf70eaf-05c9-4025-b737-094553dcf19f)
- [Michael J. Polydefkis, M.D.](https://www.keypedia.com/companies/michael-j-polydefkis-md/f67f7603-94b9-4cb8-a7c5-90751ac1dce1)
- [Wanzhu Hou, CMD, MD (CN)](https://www.keypedia.com/companies/wanzhu-hou-cmd-md-cn/e1608fee-f767-4781-98f2-bc27db2520e2)
- [Leadiant Biosciences, Inc.](https://www.keypedia.com/companies/leadiant-biosciences-inc/96da3cf1-2605-43f0-b819-2daa4c14e527)
- [Medicine Invention Design Incorporation IRB](https://www.keypedia.com/companies/medicine-invention-design-incorporation-irb/e44eb96d-12cf-40b4-bad0-077b64ce61fd)
- [Warner Graham LLLP](https://www.keypedia.com/companies/warner-graham-lllp/b7f7ddcd-3aa8-4189-8732-9a854956ce5f)
- [Tae H. Chung, M.D.](https://www.keypedia.com/companies/tae-h-chung-md/a30fcc9e-9af9-4eaf-ada7-d66551d9318e)
- [National Cancer Institute (NCI)](https://www.keypedia.com/companies/national-cancer-institute-nci/07748909-4b54-4b85-b417-cee1bfa014cf)

## Related Officers

- [Consumer Safety Officer/BIMO Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Lee Hong Pai Scherf](https://www.keypedia.com/people/lee-hong-pai-scherf/e6cb2433-ec2b-463f-8beb-5f2bc90a9291)
